Overexpression of proteolytically active, but not proteolytically inactive, PAPP‐A in an ovarian cancer cell line was shown to have increased tumor aggressiveness in vivo (Boldt & Conover, 2011). The gene discussed is PAPPA; the disease is ovarian cancer.